CVS Health price target raised to $103 from $85 at HSBC
HSBC raised the firm's price target on CVS Health to $103 from $85 and keeps a Hold rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space offering "attractiv